Clinical Trial

Chemotherapy Supported by Autologous Hematopoietic Stem Cells

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this project is to use autologous haematopoietic stem cell transfusion support to promote the reconstruction of haematopoietic function after chemotherapy for ovarian cancer. To explore the impact of stored haematopoietic stem cell support therapy on bone marrow protection after conventional chemotherapy for ovarian cancer in order to facilitate its clinical application.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-05-29.
Trial Details
NCT Number NCT05401162
Lead Sponsor Chongqing University Cancer Hospital
Conditions Ovarian Cancer
Enrollment 40 participants
Start Date 2022-04-15
Primary Completion 2027-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-29